Loading…
LB Pharmaceuticals Inc is projected to rise to $43.53 by 2027, a +32% move from its current price of $32.95. LBRX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/13/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $32.25 | $32.96 | $33.69 | +0.03% |
| Jul 15 | $31.97 | $32.97 | $34.00 | +0.07% |
| Jul 16 | $31.76 | $32.98 | $34.25 | +0.10% |
| Jul 17 | $31.59 | $32.99 | $34.46 | +0.13% |
| Jul 18 | $31.44 | $33.00 | $34.65 | +0.17% |
| Jul 19 | $31.30 | $33.02 | $34.82 | +0.20% |
| Jul 20 | $31.18 | $33.03 | $34.98 | +0.23% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $31.18 | $33.03 | $34.98 | +0.23% |
| Week 2 | $30.51 | $33.10 | $35.91 | +0.46% |
| Week 3 | $30.03 | $33.18 | $36.66 | +0.70% |
| Week 4 | $29.64 | $33.26 | $37.32 | +0.93% |
| Week 5 | $29.31 | $33.33 | $37.91 | +1.16% |
| Week 6 | $29.01 | $33.41 | $38.47 | +1.40% |
| Week 7 | $28.75 | $33.49 | $39.00 | +1.63% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on therapies for schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; it completed Phase 2 clinical trial for the treatment of bipolar I depression and adjunctive treatment of MDD, and it is in pre-clinical stage for the treatment of LAI formulation. The company was incorporated in 2015 and is headquartered in New York, New York.
LB Pharmaceuticals is categorized under Healthcare, reflecting its focus on medical therapies and clinical development.
LB Pharmaceuticals Inc trades at $32.64 per share, with a market capitalization of $936.01M and a rank of 2473. The current price sits above the SMA50 of $30.00 and well above the SMA200 of $22.68, signaling positive trend support. The technical picture shows bullish sentiment with RSI(14) at 70, a near-term resistance of $32.64, and a support level at $27.02.
The 30-day trading range runs from $27.93 to $38.15, illustrating a broad swing in the near term. Annualized volatility is 50%, underscoring a relatively elevated risk environment alongside potential upside.
A major floor 29.4% below — a decisive break under it would weaken the trend.
The nearest floor, 18.0% below — buyers have tended to step in here.
The nearest ceiling, 4.1% above — a clean break opens room to run.
A major ceiling 17.4% above — clearing it would confirm fresh momentum.
Key LBRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LBRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $33.71 | Sell | $33.39 | Sell |
| MA 10 | $33.09 | Sell | $32.88 | Buy |
| MA 20 | $31.30 | Buy | $31.83 | Buy |
| MA 50 | $30.32 | Buy | $30.21 | Buy |
| MA 100 | $28.06 | Buy | $28.11 | Buy |
| MA 200 | $23.36 | Buy | $25.05 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 60.40 | Neutral |
| Stoch RSI (14) | 29.55 | Neutral |
| CCI (20) | 61.47 | Neutral |
| Williams %R (14) | -30.32 | Info |
| MACD (12,26,9) | 0.21 | Buy |
| ROC (12) | 7.68 | Buy |
| Bollinger %B (20,2) | 0.70 | Neutral |
| Stochastic %K (14) | 69.68 | Neutral |
| TRIX (15) | 0.48 | Buy |
| Awesome (5,34) | 3.68 | Buy |
| Ultimate (7,14,28) | 60.91 | Neutral |
| Momentum (10) | 1.95 | Buy |
| Aroon Osc (25) | 52.00 | Buy |
| Hull MA (9) | 34.09 | Sell |
| ADX (14) | 23.97 | Buy |
| ATR (14) | 0.60 | Info |
In the near term, the setup is bullish with the RSI at 70 indicating strong momentum. The price is trading above the SMA50 of $30.00 and well above the SMA200 of $22.68, which supports a constructive trend. Immediate resistance is at $32.64 and immediate support is at $27.02, framing a narrow path for a breakout or pullback.
The 30-day range of $27.93 to $38.15 highlights the volatility and potential for movement within the month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $19.03 | $32.95 | $44.25 | 0% | Neutral | |
| $34.20 | $43.53 | $58.88 | +32% | Bullish | |
| $42.77 | $56.23 | $79.28 | +71% | Bullish | |
| $53.50 | $72.26 | $105.22 | +119% | Bullish | |
| $64.55 | $89.29 | $133.58 | +171% | Bullish | |
| $71.92 | $101.68 | $155.75 | +209% | Bullish | |
| $81.09 | $117.00 | $183.03 | +255% | Bullish | |
| $89.04 | $130.96 | $208.81 | +297% | Bullish | |
| $95.14 | $142.50 | $231.23 | +332% | Bullish | |
| $110.11 | $167.85 | $276.81 | +409% | Bullish | |
| $184.06 | $304.01 | $536.48 | +823% | Bullish | |
| $361.87 | $688.00 | $1,339.07 | +19.9x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $19.03 | $32.95 | $40.44 | +0.00% |
| August 2026 | $28.94 | $34.27 | $41.76 | +4.01% |
| September 2026 | $28.44 | $33.96 | $41.91 | -0.91% |
| October 2026 | $28.77 | $34.60 | $43.16 | +1.88% |
| November 2026 | $29.22 | $35.34 | $44.48 | +2.14% |
| December 2026 | $28.68 | $34.87 | $44.25 | -1.32% |
Click any year to see its month-by-month LBRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, LBRX could reach as high as $44.25, with a base case around $32.95 and support toward $19.03 — roughly 0% from $32.95. A consolidation phase looks the most probable path here.
Expect LBRX to range from $34.20 to $58.88 through 2027. The $43.53 average target implies a +32% move from current prices. That is up +32% on the projected 2026 average. Momentum favours further upside here.
The LBRX price prediction for 2028 points to an average of $56.23 (low $42.77, high $79.28) — a potential gain of +71% on today's $32.95. Buyers look set to stay in control over this stretch.
In 2029, LBRX is projected to trade between $53.50 and $105.22, averaging $72.26 — a potential gain of +119% from today's $32.95. That is up +29% on the projected 2028 average. Momentum favours further upside here.
LB Pharmaceuticals Inc's 2030 outlook centres on $89.29, within a $64.55 to $133.58 range. That is up +24% on the projected 2029 average. That marks a +171% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, LBRX could reach as high as $155.75, with a base case around $101.68 and support toward $71.92 — roughly +209% from $32.95. Momentum favours further upside here.
Expect LBRX to range from $81.09 to $183.03 through 2032. The $117.00 average target implies a +255% move from current prices. That is up +15% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The LBRX price prediction for 2033 points to an average of $130.96 (low $89.04, high $208.81) — a potential gain of +297% on today's $32.95. Momentum favours further upside here.
In 2034, LBRX is projected to trade between $95.14 and $231.23, averaging $142.50 — a potential gain of +332% from today's $32.95. That is up +9% on the projected 2033 average. Buyers look set to stay in control over this stretch.
LB Pharmaceuticals Inc's 2035 outlook centres on $167.85, within a $110.11 to $276.81 range. That is up +18% on the projected 2034 average. That marks a +409% change versus current levels. Momentum favours further upside here.
By 2040, LBRX could reach as high as $536.48, with a base case around $304.01 and support toward $184.06 — roughly +823% from $32.95. Buyers look set to stay in control over this stretch.
Expect LBRX to range from $361.87 to $1,339.07 through 2050. The $688.00 average target implies a +19.9x move from current prices. That is up +126% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in LBRX today (≈ 30.349014 LBRX) could be worth
$20,880.01
+$19,880.01 (+1988%) by 2050 · US Dollar
Based on the average projected LBRX price of $688 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LBRXwould be worth at today's price.
$1,000 invested in LBRX on Sep 11, 2025 (≈ 57.803471 LBRX) would be worth
$1,904.62
+$904.62 (+90.5%) today · 1.90× · US Dollar
Based on a LBRX entry price of $17.3 vs. today's $32.95.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $33.43 | $985.64 | -1.4% |
| 1 month ago | $28.39 | $1,160.62 | +16.1% |
| 3 months ago | $24.34 | $1,353.74 | +35.4% |
| 6 months ago | $19.03 | $1,731.48 | +73.1% |
| All time ago | $17.3 | $1,904.62 | +90.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LBRX forecast.
Our base-case forecast reaches $66.00 around 2029.
Implied market cap at $66.00: $1.89B
The multi-year forecast points to a meaningful rise in the average price over time, with notable milestones in key years. In 2026, the avg is $32.64 with a 0% ROI and neutral sentiment. By 2027 the avg climbs to $43.64 with a 33.7% ROI and bullish sentiment, and by 2028 the avg is $56.23 with a 72.3% ROI.
The 2029 forecast shows an avg of $71.14 and a 118% ROI, continuing to 2030 with an avg of $89.62 and a 174.6% ROI. The outlook remains bullish through 2031 (avg $101.10, ROI 209.7%), 2032 (avg $114.70, ROI 251.4%), and 2033 (avg $130.39, ROI 299.5%). By 2040 the avg is $297.33 and the ROI is 810.9%, while the 2050 forecast shows an avg of $668.16 with a dramatic ROI of 1947%.
These figures imply a strong upward trajectory over the long term, though they are estimates and real outcomes can vary. The sentiment is bullish in the later years, reflecting higher expected prices, but investors should consider the inherent uncertainties and market risks alongside these projections.
Tap a question to reveal the answer.
In 2030, the forecasted average price is $89.62 with a min of $63.37 and a max of $137.32. The implied ROI is 174.6% and the sentiment is bullish.
The forecast shows a bullish sentiment from 2027 onward with rising average prices, including an avg of $89.62 in 2030 and $297.33 by 2040, and a strong 2050 outlook with an avg of $668.16. ROI figures rise to 174.6% (2030), 810.9% (2040), and 1947% (2050), indicating substantial upside potential among the projected years.
The 2027 forecast lists a max of $60.01, with an avg of $43.64. Reaching near $60 is within the model’s range for 2027, though the expected average price that year is $43.64.
The 2040 forecast shows an avg price of $297.33 with a min of $171.78 and a max of $543.50. The ROI is 810.9% and the sentiment is bullish.
For 2050, the forecast shows an avg price of $668.16 with a min of $327.52 and a max of $1,355.13. The ROI is 1947% and the sentiment is bullish.
LB Pharmaceuticals Inc Community Discussion
0Share your LB Pharmaceuticals Inc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.